- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Why you should stop believing in evolution
- Innocent before proven guilty? The bizarre bipartisan rush to clear Rick Perry
- 7 grammar rules you really should pay attention to
- This is why you can't trust the NSA. Ever.
- 7 of the scariest spiders in existence
- Don't listen to Paul Ryan: The GOP is still the party of makers and takers
- 4 things NASA can teach you about a good night's sleep
- The single best way to help your kid succeed at school
- Why isn't 'Arkansas' pronounced like 'Kansas'?
- The secret to handling pressure like astronauts, Navy SEALs, and samurai
Subscribe to the Week